Flotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-κB and PI3K/Akt3 signaling pathways
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Flotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-κB and PI3K/Akt3 signaling pathways
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-07-24
DOI
10.1038/srep11614
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SiRNA-Mediated Flotillin-2 (Flot2) Downregulation Inhibits Cell Proliferation, Migration, and Invasion in Gastric Carcinoma Cells
- (2014) Ke Cao et al. ONCOLOGY RESEARCH
- Increased Expression of Flotillin-2 Protein as a Novel Biomarker for Lymph Node Metastasis in Nasopharyngeal Carcinoma
- (2014) Qiuyuan Wen et al. PLoS One
- Targeting Akt3 Signaling in Triple-Negative Breast Cancer
- (2013) Y. R. Chin et al. CANCER RESEARCH
- Increased activity of mitogen activated protein kinase pathway in flotillin-2 knockout mouse model
- (2013) Antje Banning et al. CELLULAR SIGNALLING
- Puerarin, isolated from Kudzu root (Willd.), attenuates hepatocellular cytotoxicity and regulates the GSK-3β/NF-κB pathway for exerting the hepatoprotection against chronic alcohol-induced liver injury in rats
- (2013) Rong Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- DLC-1, a candidate tumor suppressor gene, inhibits the proliferation, migration and tumorigenicity of human nasopharyngeal carcinoma cells
- (2013) XIANGLING FENG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Flotillin-2 is associated with breast cancer progression and poor survival outcomes
- (2013) Xi Wang et al. Journal of Translational Medicine
- The complexity of NF-κB signaling in inflammation and cancer
- (2013) Bastian Hoesel et al. Molecular Cancer
- Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma
- (2013) Wen Zhou et al. Molecular Cancer
- Promoter hypermethylation along with LOH, but not mutation, contributes to inactivation ofDLC-1in nasopharyngeal carcinoma
- (2013) Xiangling Feng et al. MOLECULAR CARCINOGENESIS
- Flotillin2 Expression Correlates with HER2 Levels and Poor Prognosis in Gastric Cancer
- (2013) Zhi Zhu et al. PLoS One
- miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3
- (2013) Rounak Nassirpour et al. PLoS One
- Abnormal expression of FLOT1 correlates with tumor progression and poor survival in patients with non-small cell lung cancer
- (2013) Hui Li et al. TUMOR BIOLOGY
- Lipid raft-mediated Akt signaling as a therapeutic target in mantle cell lymphoma
- (2013) M Reis-Sobreiro et al. Blood Cancer Journal
- Matrix Metalloproteinases
- (2012) Laurie A. Shuman Moss et al. AMERICAN JOURNAL OF PATHOLOGY
- Flotillin-1 Promotes Tumor Necrosis Factor-α Receptor Signaling and Activation of NF-κB in Esophageal Squamous Cell Carcinoma Cells
- (2012) Libing Song et al. GASTROENTEROLOGY
- Flotillin-1/Reggie-2 Protein Plays Dual Role in Activation of Receptor-tyrosine Kinase/Mitogen-activated Protein Kinase Signaling
- (2012) Monia Amaddii et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Flotillin-2 deficiency leads to reduced lung metastases in a mouse breast cancer model
- (2012) T Berger et al. ONCOGENE
- Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx
- (2011) Gerhard F Huber et al. BMC CANCER
- Knockdown of FLOT1 Impairs Cell Proliferation and Tumorigenicity in Breast Cancer through Upregulation of FOXO3a
- (2011) C. Lin et al. CLINICAL CANCER RESEARCH
- Lipid rafts: signaling and sorting platforms of cells and their roles in cancer
- (2011) Simon Staubach et al. Expert Review of Proteomics
- Underlying mechanisms for LTF inactivation and its functional analysis in nasopharyngeal carcinoma cell lines
- (2011) Hejun Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Interleukin 17A Promotes Hepatocellular Carcinoma Metastasis via NF-kB Induced Matrix Metalloproteinases 2 and 9 Expression
- (2011) Jian Li et al. PLoS One
- PI3K/AKT/mTOR Pathway in Angiogenesis
- (2011) Jayashree Karar et al. Frontiers in Molecular Neuroscience
- Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer
- (2010) Yanyan Zhou et al. Diagnostic Pathology
- Loss of RhoB Expression Promotes Migration and Invasion of Human Bronchial Cells Via Activation of AKT1
- (2009) E. Bousquet et al. CANCER RESEARCH
- Targeting Akt3 Signaling in Malignant Melanoma Using Isoselenocyanates
- (2009) A. Sharma et al. CLINICAL CANCER RESEARCH
- Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells
- (2009) Kyoung-Ok Hong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
- (2008) J LOPICCOLO et al. DRUG RESISTANCE UPDATES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started